C. Radulescu

1.5k citations

42 papers · 776 indexed · h-index 16

Impact in

Pulmonary and Respiratory Medicine top 10%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
Oncology top 10%
- Cancer Immunotherapy and Biomarkers

Papers in

Pulmonary and Respiratory Medicine 19
- Prostate Cancer Treatment and Research 12
- Prostate Cancer Diagnosis and Treatment 11
Oncology 13
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Thierry Lebrét Mathieu Rouanne Y. Neuzillet Yves Allory Vincent Molinié Henry Botto Alexandre de la Taille Évanguelos Xylinas
Journals: Journal of Clinical Oncology (5 papers)The Prostate (2 papers)European Radiology (2 papers)World Journal of Urology (2 papers)British Journal of Urology (2 papers)
Partner nations: France Martinique Romania

In The Last Decade

C. Radulescu

40 papers receiving 771 citations

Peers

Countries citing papers authored by C. Radulescu

Since Specialization

Citations

This map shows the geographic impact of C. Radulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Radulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Radulescu more than expected).

Fields of papers citing papers by C. Radulescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Radulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Radulescu. The network helps show where C. Radulescu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Radulescu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Radulescu Line = papers co-authored together C. Radulescu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients Pharmaceuticals ·M. Iain Smith, Hamide Dursun Zahitovic, C. Radulescu, Philippe Beuzeboc, C. Landais, R.H. Thurston, Christine L. Abraham, M.V. Chirkova, Wataru Omi, M. L. Good, Kostantinos, Juliana Gómez González, Thom P.H. Jongen, Romain‐David Seban, K. H nisch	2025	0
2	Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC Urologic Oncology Seminars and Original Investigations ·Myriam Kossaï, C. Radulescu, Julien Adam, 张明华, Nicolas Signolle, Mathilde Sibony, Thierry Lebrét, Yves Allory, Mathieu Rouanne	2021	9
3	A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models Nuclear Medicine and Biology ·Jules Zhang-Yin, C. Provost, Géraldine Cancel‐Tassin, Fernando Costenaro, Боев Николай Васильевич, C. Radulescu, Éva Compérat, Olivier Cussenot, Françoise Montravers, Raphaële Renard‐Penna, Jean‐Noël Talbot, Aurélie Prignon	2020	15
4	PD-L1 testing in urothelial bladder cancer: essentials of clinical practice World Journal of Urology ·Mathieu Rouanne, C. Radulescu, Julien Adam, Yves Allory	2020	12
5	c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression Nature Communications ·Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Katherine P. Wallerius, Luis A. Medina, C. M. REMSEN, Eytan Domany, Dennis Kappei, Tuan Zea Tan, Kayla M Natali, Patrick Jaynes, Chandra Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, C. Radulescu, Peter ten Dijke, Pieter J.A. Eichhorn, Jean Paul Thiery	2019	48
6	Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score PLoS ONE ·Marie Simon, Dimitar Davidov, Mathieu Rouanne, Simone Benhamou, C. Radulescu, Vincent Molinié, Y. Neuzillet, Xavier Paolettí, Thierry Lebrét	2019	19
7	Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer European Radiology ·Antoine Girard, Mathieu Rouanne, Ringe Arne, C. Radulescu, Y. Neuzillet, Danielle De Jonge, Aurélie Bèaufrere, Thierry Lebrét, Elise Le Stanc, 健徳丹羽	2019	40
8	Utilité des examens extemporanés lors de la cystectomie totale pour carcinome urothélial Progrès en Urologie ·A Shoemaker, C. Radulescu, Y. Neuzillet, Mathieu Rouanne, Thierry Lebrét	2019	1
9	From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients PLoS ONE ·А. Т. Филянин, C. Radulescu, M Chaignon, Alexandre Karras, Y. Neuzillet, Jean–Paul Duong Van Huyen, Nahid Tabibzadeh, Emmanuel Letavernier, Michel Delahousse, Jean‐Philippe Haymann	2018	7
10	Le delai entre biopsies de prostate et prostatectomie radicale influence-t-il le risque de recidive ? Progrès en Urologie ·M Meunier, Y. Neuzillet, C. Radulescu, Karen DePastel, Jean-Marie Hervé, Mathieu Rouanne, Vincent Molinié, Thierry Lebrét	2018	10
11	Tim-3 médecine/sciences ·Clémence Granier, Alain Gey, Charles Dariane, Arnaud Méjean, Marc‐Olivier Timsit, Charlotte Blanc, Virginie Verkarre, C. Radulescu, Elizabeth Fabre, Yann Vano, Stéphane Oudard, Cécile Badoual, Éric Tartour	2018	4
12	Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results Hormones and Cancer ·Y. Neuzillet, Jean‐Pierre Raynaud, Jean‐François Dreyfus, C. Radulescu, Mathieu Rouanne, Cecelia B. Sirigos, Bańkowski, Morgan Rouprêt, Sarah Drouin, Éva Compérat, Marc Galiano, Xavier Cathelineau, Pierre Validire, Vincent Molinié, Jean Fiet, Frank Giton, Thierry Lebrét, Henry Botto	2018	22
13	Gleason Score within Prostate Abnormal Areas Defined by Multiparametric Magnetic Resonance Imaging Did Not Vary According to the PIRADS Score Urologia Internationalis ·Joana Pereira Festas, Y. Neuzillet, T. Ghoneim, Mathieu Rouanne, Lori A. Hillsman, Kaili Palts, Antoine Scherrer, C. Radulescu, Robert J. Kerr, Vincent Molinié, Thierry Lebrét	2017	17
14	Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma Cancer Research ·Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saı̈k Urien, Cécile Badoual, Hélène Roussel, Marion Mandavit, Patrice Ravel, Mathilde Sibony, Lucie Biard, C. Radulescu, Emeline Vinatier, Nadine Benhamouda, Michaël Peyromaure, Stéphane Oudard, Arnaud Méjean, Marc‐Olivier Timsit, Alain Gey, Éric Tartour	2016	163
15	Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen Hormone Molecular Biology and Clinical Investigation ·Y. Neuzillet, Jean‐Pierre Raynaud, Thierry Lebrét, M. Y. Pac, C. Radulescu, Vincent Molinié, Henry Botto	2015	4
16	Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading Prostate Cancer and Prostatic Diseases ·M. Y. Pac, Y. Neuzillet, Henry Botto, Demeke Adugnaw, C. Radulescu, Vincent Molinié, 麻衣子天野, Thierry Lebrét	2015	29
17	Positive surgical margins after radical prostatectomy: What should we care about? World Journal of Urology ·C. Pettenati, Y. Neuzillet, C. Radulescu, Jean-Marie Hervé, Vincent Molinié, Thierry Lebrét	2015	18
18	Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer World Journal of Surgical Oncology ·Mathieu Rouanne, Yunwu Han, D. Vilain, C. Radulescu, Thierry Lebrét	2015	7
19	The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy British Journal of Urology ·Xavier Durand, Évanguelos Xylinas, C. Radulescu, R. Haus-Cheymol, Stéphane Moutereau, Angelica Afshari-Mehr, Che-Han Lin, G. Robert, Francis Vacherot, Sylvain Loric, Yves Allory, A. Ruffion, Alexandre de la Taille	2012	49
20	A Double Blind, Randomized, Controlled Investigation of Electrodermal Testing in the Diagnosis of Allergies The Journal of Alternative and Complementary Medicine ·Julie Krop, George Lewith, H. Michel, C. Radulescu	1997	17

About C. Radulescu

C. Radulescu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Surgery and Urology, having authored 42 papers that have together received 776 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Urinary and Genital Oncology Studies (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Urologic and reproductive health conditions (6 papers), Hormonal and reproductive studies (5 papers) and Sexual Differentiation and Disorders (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (355 citations), Oncology (255 citations), Urology (57 citations), Cancer Research (129 citations) and Surgery (251 citations). C. Radulescu has collaborated with scholars based in France, Martinique and Romania. Frequent co-authors include Thierry Lebrét, Mathieu Rouanne, Y. Neuzillet, Yves Allory, Vincent Molinié, Henry Botto, Alexandre de la Taille, Évanguelos Xylinas, Francis Vacherot and Sylvain Loric. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, European Radiology, World Journal of Urology and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact